Company: CRESW
Filing Date: 2025-03-17
Form Type: 6-K
Source: 0001654954-25-002875
Chunk: 19

Company: CRESUD INC
Filing Date: 2025-03-17
Form: 6-K
Chunk 19
---
101,611 |     96,889 |

Véase nuestro informe de fecha 11/11/22

PRICE WATERHOUSE & Co. S.R.L.

C.P.C.E.C.A.B.A. T° 1 F° 17

<div align='center'>19</div>

#### Cresud Sociedad Anónima,
<div align='center'>**Comercial, Inmobiliaria, Financiera y Agropecuaria**</div>

The depreciation charge of the right of use assets is detailed below:

|                                   | 12.31.2024 | 12.31.2023 |
| Farmland                          |      8,842 |      8,411 |
| Convention                        
 center                            |        403 |        341 |
| Offices, shopping                 
 malls and other buildings         |        746 |        806 |
| Machinery and                     
 equipment                         |        595 |        394 |
| Depreciation                      
 charge of right-of-use assets (i) |     10,586 |      9,952 |

(I) As of December 31, 2024, the amortization charge has been allocated ARS 649 within "Costs", ARS 242 in "General and administrative expenses" and ARS 258 in “Selling expenses” in the Statement of Income and Other Comprehensive Income (Note 24), ARS 9,437 were capitalized as part of the cost of biological assets.

The Group’s lease liabilities as of December 31, 2024 and June 30, 2024 are the following:

|                           | 12.31.2024 | 06.30.2024 |
| Farmland                  |     91,376 |     82,304 |
| Convention                
 center                    |      2,153 |     10,867 |
| Offices, shopping         
 malls and other buildings |      2,943 |      3,466 |
| Lease                     
 liabilities               |     96,472 |     96,637 |
| Non-current               |     75,723 |     74,184 |
| Current                   |     20,749 |     22,453 |
| Total                     |     96,472 |     96,637 |

#### 13.

#### Biological assets
Changes in the Group’s biological assets and their allocation to the fair value hierarchy for the six-month period ended December 31, 2024 and for the year